Structure-Based Drug Discovery

Discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission. Structure-based drug discovery methods have been transformed in the last 5-10 years and are now having a major impact on the discovery of new drugs. Some of...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Jhoti, Harren (Συγγραφέας), Leach, Andrew R. (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Dordrecht : Springer Netherlands, 2007.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03278nam a22005295i 4500
001 978-1-4020-4407-6
003 DE-He213
005 20151204152904.0
007 cr nn 008mamaa
008 100301s2007 ne | s |||| 0|eng d
020 |a 9781402044076  |9 978-1-4020-4407-6 
024 7 |a 10.1007/1-4020-4407-0  |2 doi 
040 |d GrThAP 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a SCI013020  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
100 1 |a Jhoti, Harren.  |e author. 
245 1 0 |a Structure-Based Drug Discovery  |h [electronic resource] /  |c by Harren Jhoti, Andrew R. Leach. 
264 1 |a Dordrecht :  |b Springer Netherlands,  |c 2007. 
300 |a XII, 250 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Five Years of Increasing Structural Biology Throughput - A Retrospective Analysis -- Protein Production for Structural Genomics - Strategies for the Next Phase -- to Fragment Screening -- Fragment-Based NMR Screening in Lead Discovery -- Fragment-Based Screening by X-ray Crystallography -- Scaffold-Based Drug Discovery -- Biophysical Methods -- Illustration of Current Challenges in Molecular Docking -- Scoring Functions. 
520 |a Discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission. Structure-based drug discovery methods have been transformed in the last 5-10 years and are now having a major impact on the discovery of new drugs. Some of the most exciting developments in the field, such as Fragment-based methods, are described in this book. Structure-based drug discovery describes the latest developments in technologies that can be used to obtain the 3-D structures including the high profile structural genomics approaches being used worldwide. The use of 3-D protein structures in new, Fragment-based, approaches to drug discovery are described in some detail. This book includes experimental approaches using X-ray crystallography and NMR for Fragment-based screening as well as other biophysical methods for studying protein/ligand interactions. In addition, developments in computational chemistry methodology are covered together with an assessment of practical applications. This book is an invaluable resource for medicinal chemists in industry, computational chemists, drug discovery scientists and postgraduates in chemistry or structural biology. 
650 0 |a Chemistry. 
650 0 |a Pharmacy. 
650 0 |a Pharmacology. 
650 0 |a Physical chemistry. 
650 0 |a Medicinal chemistry. 
650 0 |a Biochemistry. 
650 1 4 |a Chemistry. 
650 2 4 |a Medicinal Chemistry. 
650 2 4 |a Biomedicine general. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Biochemistry, general. 
650 2 4 |a Pharmacy. 
650 2 4 |a Physical Chemistry. 
700 1 |a Leach, Andrew R.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781402044069 
856 4 0 |u http://dx.doi.org/10.1007/1-4020-4407-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-CMS 
950 |a Chemistry and Materials Science (Springer-11644)